Cellcept and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Decadron (dexamethasone). Common drug interactions include diarrhoea among females and lymphoma among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Decadron. It is created by eHealthMe based on reports of 82 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

On Jul, 22, 2026

82 people who take Cellcept and Decadron together, and have interactions are studied.

Cellcept and Decadron drug interactions.

What are the common drug interactions of Cellcept and Decadron, by gender? *:

female:

Diarrhoea
Gastroenteritis (inflammation of stomach and intestine)
Hyperlipidaemia (presence of excess lipids in the blood)
Myalgia (muscle pain)
Nephrogenic anaemia (anaemia due to kidney disease)
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Rhinitis allergic (inflammation of the nasal airways due to allergy)
Cystitis (inflammation of the wall of the bladder)
Dyslipidaemia (abnormal amount of lipids)
Nasopharyngitis (inflammation of the nasopharynx)

male:

Lymphoma (cancer that begins in immune system cells)
Blood creatinine increased
Hyperbilirubinaemia (excess of bilirubin in the blood)
Nephritis interstitial (a kidney condition characterized by swelling in between the kidney tubules)
Pyrexia (fever)
Urticaria (rash of round, red welts on the skin that itch intensely)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Death
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)

What are the common drug interactions of Cellcept and Decadron, by age (0-1 to 60+)? *:

0-1:

Acute respiratory distress syndrome
Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Electrocardiogram qt prolonged
Gastric ulcer (stomach ulcer)
Hypokalaemia (low potassium)
Liver disorder (liver diseases)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Pancreatitis (inflammation of pancreas)
Pneumocystis jiroveci pneumonia (fungal infection of the lungs)

2-9:

Hypertension (high blood pressure)
Infection

10-19:

Back pain
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood alkaline phosphatase increased
Blood lactate dehydrogenase increased
Blood potassium increased
Blood sodium decreased
Cardiac arrest
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Depressed level of consciousness
Disseminated intravascular coagulation (systemic activation of blood coagulation)

20-29:

Pneumonia
Appendicitis (inflammation of the appendix)
Back pain
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Gastroenteritis (inflammation of stomach and intestine)
Hyperlipidaemia (presence of excess lipids in the blood)
Myalgia (muscle pain)
Nephrogenic anaemia (anaemia due to kidney disease)
Pharyngitis (inflammation of the pharynx, causing a sore throat)

30-39:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Anaemia (lack of blood)
Leukopenia (less number of white blood cells in blood)
Liver disorder (liver diseases)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Hip arthroplasty
Hyperkalaemia (damage to or disease of the kidney)
Hypoxia (low oxygen in tissues)

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Breast cancer metastatic
Metastases to bone (cancer spreads to bone)
Metastases to central nervous system (cancer spreads to central nervous system)
Metastases to liver (cancer spreads to liver)
Metastases to lymph nodes (cancer spreads to lymph node)
Alopecia (absence of hair from areas of the body)
Blood creatinine increased
Dizziness
Drug effect decreased

50-59:

Cough
Diarrhoea
Flushing (the warm, red condition of human skin)
Heart rate decreased
Heart rate increased
Heart rate irregular
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Lower respiratory tract infection
Nasopharyngitis (inflammation of the nasopharynx)
Pain

60+:

Blood creatinine increased
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Urticaria (rash of round, red welts on the skin that itch intensely)
Vomiting
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Dehydration (dryness resulting from the removal of water)
Hair disorder
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 7 people, 8.54%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 7 people, 8.54%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 6 people, 7.32%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 6 people, 7.32%
High Blood Pressure: 5 people, 6.10%
Diarrhea: 5 people, 6.10%
Breast Cancer Female: 5 people, 6.10%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously